Ataxin 2 Antikörper (AA 775-856) (AbBy Fluor® 350)
-
- Target Alle Ataxin 2 (ATXN2) Antikörper anzeigen
- Ataxin 2 (ATXN2)
-
Bindungsspezifität
- AA 775-856
-
Reaktivität
- Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Ataxin 2 Antikörper ist konjugiert mit AbBy Fluor® 350
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Maus
- Homologie
- Human,Rat,Dog,Cow,Pig,Horse,Chicken
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human ATX2
- Isotyp
- IgG
- Top Product
- Discover our top product ATXN2 Primärantikörper
-
anti-Ataxin 2 (ATXN2) antibody
ATXN2 Reaktivität: Human, Maus, Ratte IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Ataxin 2 (ATXN2) (C-Term) antibodyATXN2 Reaktivität: Human, Maus, Ratte WB, IF, ICC, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Ataxin 2 (ATXN2) (AA 775-856) antibodyATXN2 Reaktivität: Maus WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Ataxin 2 (ATXN2) (Internal Region) antibodyVerified ATXN2 Reaktivität: Human ELISA, IF, FACS Wirt: Ziege Polyclonal unconjugated
anti-Ataxin 2 (ATXN2) (AA 713-904) antibodyATXN2 Reaktivität: Human, Ratte WB, IF Wirt: Maus Monoclonal 22-Ataxin unconjugated
anti-Ataxin 2 (ATXN2) (AA 1283-1313), (C-Term) antibodyATXN2 Reaktivität: Human, Maus, Ratte WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Ataxin 2 (ATXN2) (AA 174-383) antibodyATXN2 Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Ataxin 2 (ATXN2) (Internal Region) antibodyATXN2 Reaktivität: Human WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Ataxin 2 (ATXN2) (AA 725-757) antibodyATXN2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB53601 unconjugated
anti-Ataxin 2 (ATXN2) (AA 321-355) antibodyATXN2 Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal RB53600 unconjugated
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- Ataxin 2 (ATXN2)
- Andere Bezeichnung
- ATX2 (ATXN2 Produkte)
- Synonyme
- ASL13 antikoerper, ATX2 antikoerper, SCA2 antikoerper, TNRC13 antikoerper, 9630045M23Rik antikoerper, AW544490 antikoerper, Sca2 antikoerper, ATXN2 antikoerper, MGC115230 antikoerper, ataxin 2 antikoerper, ataxin 2 L homeolog antikoerper, ATXN2 antikoerper, Atxn2 antikoerper, atxn2.L antikoerper
- Hintergrund
-
Synonyms: ATX2, SCA2, ASL13, TNRC13, Ataxin-2, Spinocerebellar ataxia type 2 protein, Trinucleotide repeat-containing gene 13 protein, ATXN2
Background: The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ATX2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. ATX2 is caused by expansion of a CAG repeat in the coding region of ATX2. Longer expansions result in earlier onset of the disease. There are four named isoforms.
- Gen-ID
- 6311
- UniProt
- Q99700
- Pathways
- Ribonucleoprotein Complex Subunit Organization
-
